Medicofarma Biotech SA (WSE:MDB)
Poland · Delayed Price · Currency is PLN 0.4060
-0.0040 (-0.98%)
At close: Jul 24, 2026
Medicofarma Biotech Market Cap
Medicofarma Biotech has a market cap or net worth of 27.6 million as of July 24, 2026. Its market cap has increased by 23.03% in one year.
Market Cap
27.60M
Enterprise Value
31.51M
Revenue
43.90K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.41
ChartMarket Cap Chart
Since January 30, 2009, Medicofarma Biotech's market cap has increased from 6.50M to 27.60M, an increase of 324.60%. That is a compound annual growth rate of 8.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 27.60M | 1.75% |
| Dec 30, 2025 | 27.12M | 2.84% |
| Dec 30, 2024 | 26.38M | -64.24% |
| Dec 29, 2023 | 73.76M | -6.06% |
| Dec 30, 2022 | 78.51M | -32.05% |
| Dec 30, 2021 | 115.54M | 483.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 5.53B |
| NEUCA | 3.36B |
| Synektik Spólka Akcyjna | 3.07B |
| Voxel | 1.26B |
| Sygnis | 37.36M |
| Pharmena | 34.64M |
| Airway Medix | 32.46M |
| Pure Biologics | 26.20M |